Federal inspectors discovered the medication switch at Belpre Landing Nursing and Rehabilitation during a November complaint investigation. The resident's pain medication had been carefully removed from sealed blister packs and substituted with loratadine, an over-the-counter allergy drug.
The tampering was sophisticated. Someone had made small slits in the backing of individual medication bubbles, removed the oxycodone tablets, and inserted different pills before resealing the packaging. Inspectors found the altered medications across two separate blister cards filled months apart.
Blister card number one, filled March 26, contained 30 oxycodone tablets originally. Twelve had been legitimately removed for the resident's use, leaving 18 remaining. Of those 18 pills, 12 bubbles showed small slits in the backing. The tablets inside those compromised bubbles had different markings than authentic oxycodone pills.
Some replacement tablets were marked with "10's" while others showed "K/18" imprints. None matched the original oxycodone specifications.
The second blister card, filled May 20, held 30 tablets with 15 bubbles showing identical slit marks. A contracted pharmacist later confirmed those 15 tablets were loratadine 10 mg pills substituted for the prescribed oxycodone.
The facility's Director of Nursing remained present while inspectors examined the tampered packaging. She acknowledged that their contracted pharmacist had already identified the medication substitution during an on-site visit July 16.
The pharmacist had documented the findings in an email included in the facility's investigation file. The evidence clearly showed someone had accessed the resident's controlled substance and replaced it with a different medication entirely.
But the administrator refused to classify the incident as medication theft.
He denied that misappropriation had occurred because their investigation couldn't prove who took the pills. When inspectors pointed out that proving identity wasn't required to establish misappropriation, he acknowledged this fact but maintained his position.
"He acknowledged they did not have to prove who took the medication to show evidence of misappropriation of a resident's medication had occurred, only that there were doses unaccounted for that had not been used by the resident," the inspection report stated.
The administrator admitted that some of the resident's oxycodone had been replaced with loratadine. He acknowledged those missing oxycodone tablets "were not used for the resident as they were intended to be."
Despite this acknowledgment, he refused to file a required incident report with state authorities. The administrator said he didn't feel their investigation proved misappropriation had occurred, even though medication intended for the resident had clearly been diverted.
The facility's own policy contradicted the administrator's reasoning. Their Abuse Prohibition policy explicitly states that residents "would not be subjected to the misappropriation of their property by anyone."
The policy defines misappropriation as "depriving, defrauding, or otherwise obtaining the real or personal property of a resident by any means prohibited by the Revised Code." It includes "patterned or deliberate misplacement, exploitation, or wrongful, temporary or permanent use of a resident's belongings or money without the resident's consent."
Under facility policy, all alleged violations involving abuse, neglect, and misappropriation must be immediately reported to the administrator. More critically, the results of thorough investigations must be reported to the Ohio Department of Health within five working days.
The administrator failed to make this required report despite clear evidence that someone had systematically accessed and diverted a resident's controlled substance medication.
The medication switch represented a serious breach of pharmaceutical security. Oxycodone is a Schedule II controlled substance with strict handling requirements due to its addiction potential and street value. Someone with access to the facility's medication storage had deliberately targeted this resident's pain medication.
The substituted loratadine provides no pain relief and would have left the resident without their prescribed treatment. For someone dependent on opioid medication for pain management, the sudden absence of effective medication could cause significant suffering.
The tampering occurred across multiple months, suggesting ongoing access to the medication storage system. The March and May blister cards showed identical alteration methods, indicating the same person likely committed both thefts.
The facility's contracted pharmacist had the expertise to immediately identify the substituted medications during the July inspection. This suggests the tampering was obvious to anyone with pharmaceutical knowledge who examined the packaging closely.
Yet the medication remained in circulation for months before discovery. The timeline indicates the resident may have unknowingly received ineffective medication during that period, depending on which tablets were dispensed.
The administrator's refusal to report the incident violated both facility policy and federal requirements. Nursing homes must report suspected medication diversion to protect residents and prevent additional thefts.
The inspection occurred as part of a complaint investigation, suggesting someone had raised concerns about medication handling at the facility. The specific complaint that triggered the inspection was not detailed in the available report.
Federal inspectors classified the violation as causing minimal harm with few residents affected. However, the systematic nature of the tampering and the failure to report it properly raised broader questions about medication security protocols.
The resident whose medication was stolen faced the prospect of inadequate pain management while someone else potentially abused their prescribed oxycodone. The administrator's decision not to report the theft left other residents vulnerable to similar medication diversion.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Belpre Landing Nursing and Rehabilitation from 2025-11-24 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Belpre Landing Nursing and Rehabilitation
- Browse all OH nursing home inspections